| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.076 | 0.2 |